Last Price
12.40
Today's Change
-0.06 (0.48%)
Day's Change
12.27 - 12.47
Trading Volume
51,581
Overview
Market Cap
1 Billion
Shares Outstanding
84 Million
Avg Volume
781,839
Avg Price (50 Days)
11.06
Avg Price (200 Days)
11.79
PE Ratio
-7.65
EPS
-1.62
Earnings Announcement
11-Mar-2025
Previous Close
12.46
Open
12.45
Day's Range
12.275 - 12.47
Year Range
8.26 - 16.99
Trading Volume
51,581
Price Change Highlight
1 Day Change
-0.48%
5 Day Change
2.65%
1 Month Change
15.35%
3 Month Change
12.32%
6 Month Change
-0.80%
Ytd Change
2.48%
1 Year Change
-1.82%
3 Year Change
82.09%
5 Year Change
173.73%
10 Year Change
11.71%
Max Change
11.71%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
US Fed’s Waller Supports Further Cuts, Says Inflation Moving Lower
2
CEO Morning Brief
3
CEO Morning Brief
4
CEO Morning Brief
Tesla Poised for US$1 Bil Windfall From EU’s Emissions Curbs
5
CEO Morning Brief
US 30-year Mortgage Rate Just Shy of 7% Bridles Home Purchases
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
